Winnerblog328

Medical robotics is a new and an emerging field of science. Varian Medical Systems. January 28th, 2021. Market Growth Insight Releases. Opportunities, drivers, industry-specific. Varian Valuation Drivers Correlation Many accounts on the financial statements of Varian Medical Systems are highly interrelated and sometimes correlated. Consequently, when conducting Varian's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation.

Feb 09, 2021 Varian Medical Systems, Inc. Senior Software Engineer / Medical Devices (m/f/d) Varian Medical Systems, Inc. Software Sales Specialist, Turkey: Varian Medical Systems, Inc. Istanbul: Logistic Analyst: Varian Medical Systems, Inc. Istanbul: Sr Product Designer: Varian Medical Systems, Inc. Installed Base Sales Manager, Philippines: Varian.

DUBLIN--(BUSINESS WIRE)--The 'Global Radiotherapy Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024' report has been added to Research and Markets' offering.

In this report, global radiotherapy market is projected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.

Scope of the Report

• The global radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy.
• Radiotherapy market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy.
• The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology.
• The brachytherapy is segmented into LDR and HDR.
• On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software and systematic radiotherapy.
• External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife.
• The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders.
• The radiotherapy software is segmented into treatment planning softwares, dosage planning softwares, patient positioning software and image guiding softwares.
• On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.

Market Overview

Drivers

• Growing Prevalence of Cancer
• Rising Ageing Population
• Unhealthy Lifestyle
• Mergers and Acquisitions to Expand Business

Restraints

• Regulatory Scenario
• High Cost of Radiotherapy

Opportunities

• Growing Medical Tourism in Asia
• Emerging Market

Challenges

• Side-Effects of Radiotherapy
• Requirement of Trained Staff

Global radiotherapy market competition by top players including:

Varian Medical Systems, Inc. dominated the radiotherapy market followed by Elekta AB, and Accuray, Inc. along with others

• CIVCO Medical Solutions
• Brainlab AG
• C. R. Bard, Inc.
• IsoRay Medical, Inc.
• Nordion, Inc.
• RaySearch Laboratories AB
• PRECISIS AG
• Mevion Medical Systems, Inc.
• TechnicasRadiofiscas S.L.
• Hitachi, Ltd.
• Sumitomo Heavy Industries, Ltd.
• Mitsubishi Electric Corporation
• ProNova Solutions, LLC
• ProTom International

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global Radiotherapy Market, by Therapy Type

7. Global Radiotherapy Market, by Product Type

8. Global Radiotherapy Market, by Indication

9. Global Radiotherapy Market, by Geography

10. Global Radiotherapy Market, Company Share

11. Company Profiles

• Accuray, Inc.
• Brainlab AG
• C. R. Bard, Inc.
• CIVCO Medical Solutions
• Elekta AB,
• Hitachi, Ltd.
• IsoRay Medical, Inc.
• Mevion Medical Systems, Inc.
• Mitsubishi Electric Corporation
• Nordion, Inc.
• PRECISIS AG
• ProNova Solutions, LLC
• ProTom International
• RaySearch Laboratories AB
• Sumitomo Heavy Industries, Ltd.
• TechnicasRadiofiscas S.L.
• Varian Medical Systems, Inc.

Drivers Varian Medical Supplies

For more information about this report visit https://www.researchandmarkets.com/research/483p8l/global

Drivers Varian Medical System

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Varian Medical (NYSE:VAR), known for its use of rfxcel serialization software , said today it launched an FDA-cleared version of its Velocity cancer imaging software, including a new Rapidsphere module.

Drivers Varian Medical Company

The newly launched Velocity 4.0’s Rapidsphere module is designed for Y90 selective internal radiation therapy dosimetry analysis and provides improved information on tumor responses and normal-tissue toxicity for patients undergoing SIRT, the Palo Alto, Calif.-based company said.

Drivers Varian Medical Company

The Velocity 4.0 software includes the company’s Velocity M3i multi-modality motion imaging component, the Velocity Aria sync component and the Velocity tumor & dose tracking component.

“At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients. Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor’s response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT,” Varian oncology systems biz prez Kolleen Kennedy said in a press release.

Drivers Varian Medical Stock

Last week, Brainlab said it inked a deal with Varian looking to support interoperability between Brainlab’s ExacTrac and Varian’s Clinac platform, TrueBeam and Edge systems.